Skip to main content
Premium Trial:

Request an Annual Quote

UK Government Awards CellCentric $2M to Develop Epigenetic Cell-Based Screens

NEW YORK, May 4 (GenomeWeb News) - The UK's Department of Trade and Industry has awarded CellCentric £1.15 million ($2.1 million) to support development of cell-based screens for proteins and small molecules responsible for epigenetic changes, the company said today.

 

The DTI's Technology Program provided the funding as part of a £2.3 million, three-year program that also includes the Gurdon Institute and the Babraham Institute at the University of Cambridge and the University of Nottingham.

 

The epigenetic screens are expected to have applicability in bioprocessing, regenerative medicine, and cancer therapeutics, CellCentric said.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.